Đang chuẩn bị liên kết để tải về tài liệu:
Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells

Trastuzumab is the only approved target agent for the first-line treatment of human epidermal growth factor receptor-2 (HER-2) positive gastric cancer; however, trastuzumab resistance is a major problem in clinical practice. |